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The Kaplan-Meier product-limit estimator is a
simple and powerful tool in time to event analysis. An
extension exists for populations stratified into cohorts
where a population survival curve is generated by
weighted averaging of cohort-level survival curves.
For making population-level comparisons using this
statistic, we analyze the statistics of the area between
two such weighted survival curves. We derive the
large sample behavior of this statistic based on an
empirical process of product-limit estimators. This
estimator was used by an interdisciplinary NIH-
SSA team in the identification of medical conditions
to prioritize for adjudication in disability benefits
processing.
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1. Introduction
Survival analysis addresses the classical statistical problem of determining characteristics of the
waiting time until an event, canonically death, from observations of their occurrence sampled
from within a population. This problem is not trivial as the expected waiting time is typically
dependent on the time-already-waited. For instance, a hundred-year-old can be more certain
of surviving to his or her one hundred and-first birthday than a newborn might reasonably
be. However, the comparison may shift in the newborn’s favor for the living to one-hundred
and twenty-one, particularly in light of medical advances that make survival probabilities non-
stationary. Parametric approaches for assembling survival curves are usually not flexible enough
to capture this complexity.
One simple approach to this problem was pioneered by the work of Kaplan and Meier [9].
Their product-limit estimator [6,7,19,20] is a non-parametric statistic that is used for inferring
the survival function for members of a population from observed lifetimes. This method is
particularly useful in that it naturally handles the presence of right censoring, where some event-
times are only partially observed because they fall outside the observation window. It was not,
however, designed to account for varying subpopulations that may yield non-homogeneity in
overall population survival (Fig. 1). For instance, in the example given above, subpopulations for
survival characteristics may be defined by birth year or entry cohort of a subject in a particular
study (Fig. 1).
Several existing statistical methods address variants of this limitation. A natural approach
is to consider the varying subpopulations as defining underlying covariates, thus laying the
framework for a proportional hazards model. The assumption of proportional hazards is quite
strong. When considering time-dependent statistics (as in the motivational example), it is violated
in all but a few specific cases. Likewise, frailty models, first developed by Hougaard (cf. [8]), and
extended by Aalen (cf. [1]), assume multivariate event distributions, but also make assumptions
on the underlying event distributions and assume proportional hazards.
Other existing methods, such as bivariate survival analysis (cf. [12]), consider the time to
observation and the time to event as conditionally independent random times. Underlying these
methods is the assumption that upon the time of observation, all individuals will then have a
similar event time distribution, thus failing to acknowledge the temporal changes.
These complexities arose in the identification of new disorders to incorporate into the United
States Social Security Administration (SSA)’s Compassionate Allowances (CAL) initiative. The
CAL initiative seeks to identify candidate medical conditions for fast-tracking in the processing
of disability applications. The intent of this initiative is to prioritize applicants who are most
likely to die in the time-course of usual case processing so that they may receive benefits while
still living.
At its inception, the CAL initiative identified conditions based on the counsel of expert
opinion [17]. The SSA in collaboration with the National Institutes of Health (NIH) sought to
expand the list of CAL conditions systematically, using a data-based approach. Using in-part the
survival estimator described in this manuscript, the NIH identified 24 conditions for inclusion
into the list of conditions [17].
The methodology used in CAL is related to that of the work of Pepe and Fleming (cf. [15,16]),
where a class of weighted Kaplan-Meier statistics is introduced. Though these statistics exhibit
the same limitations as in the standard Kaplan-Meier case, it should be noted that [16] introduces
the stratified weighted Kaplan-Meier statistic. The statistic presented here is a priori quite similar,
but instead of a weighting function, includes the empirical prevalence. In doing so, the weight is
no longer independent of the event time estimate, and thus requires much different methods of
proof.
We thus consider the overall survival distribution for a population of individuals with sub-
populations that exhibit non-homogeneous survival distributions. Through this consideration,
a new test statistic, based upon the empirical process of product-limit estimators is developed.
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Figure 1. Inhomogeneity of survival within populations can result due to at least two reasons. In (a), inhomogeneity
results from a categorical covariate that influences survival statistics. In (b), inhomogeneity results from non-stationarity,
where cohorts of individuals are sampled at different times. In this case, the problem of progressive censoring is apparent
because later cohorts have not been observed as long.
Through constructive methods, this test-statistic compares survival distributions among the
distinct subpopulations, and weights according to distribution of the identified subgroups.
2. Statistical method
Suppose Γ (1) and Γ (2) are disjoint populations of individuals where each individual belongs to
exactly one of d distinct cohorts labeled z ∈Zd. For randomly selected individuals γ ∈ Γ (i) within
population i, we desire to understand the statistics of the event time T γ under the assumption
that survival is conditional on cohort zγ and population.
One representation of the marginal survival probability for members of population i, θ(i)t =
P
{
T γ > t | γ ∈ Γ (i)
}
, is found by conditioning on cohort,
θ
(i)
t =
d∑
z=1
P
{
T γ > t | zγ = z, γ ∈ Γ (i)
}
︸ ︷︷ ︸
S
(i)
z,t
P
{
zγ = z | γ ∈ Γ (i)
}
︸ ︷︷ ︸
q
(i)
z
, (2.1)
where S(i)z,t represents the survival function for individuals of cohort z in population i, where each
individual’s cohort membership is known.
We use this representation of the survival probability as motivation to formulate an estimator
for the population-average survival functions
θˆ
(i)
t =
d∑
z=1
qˆ
(i)
z Sˆ
(i)
z,t, (2.2)
where qˆ(i)z and Sˆ
(i)
z,t are estimators of the cohort prevalence and cohort-wise survival respectively.
This weighted Kaplan Meier method has appeared previously in the literature [14], and has been
empirically validated against the pure Kaplan Meier method [22], where the weighting procedure
was found to reduce the bias in the construction of survival curves. The asymptotic convergence
of the product-limit estimator and weighted variants is well established [4,16]. We use this
survival curve reconstruction method as a base in constructing a new statistic for comparing
populations. The focus of this manuscript is not the properties of this survival estimator but rather
the asymptotic convergence of its bounding area and the use of such a quantity for evaluating a
null hypothesis.
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Our concern is the general situation where random samples of size n(i) are chosen from each of
the respective populations. Within these samples, the number of individuals within each cohort,
n
(i)
z , is counted, from which an estimator of the cohort distribution is obtained,
qˆ
(i)
z =
n
(i)
z
n(i)
. (2.3)
In turn, we assume that the cohort-level survival functions Sˆ(i)z,t are estimated independently
using the product-limit estimator. Note that since the product limit estimator is not a linear
functional of sampled lifetimes, θˆ(i)t is distinct from the estimator obtained by applying the
product limit estimator directly on all n(i) samples of population i. To prevent confusion, we
denote all direct applications of the product-limit estimator using Sˆ and all instances of weighted
sums of product limit estimators using the Greek letter θˆ.
With these elements in place, we define our test statistic
Θˆ=
√
n(1)n(2)
n(1) + n(2)
∫τ
0
dt
(
θˆ
(1)
t − θˆ(2)t
)
, (2.4)
where τ = inf {τz : z ∈Zd}, and τz denotes the time at which cohort z is censored in observations.
Note that in the absence of censoring this statistic is equivalent to comparison of mean lifetimes
between the two populations [15]. We state here the main result of the paper – the large sample
behavior of this statistic within a null-hypothesis statistical testing framework.
Theorem 1. Let C(i)z,t denote the probability that a z-type individual has not yet been censored at time
t≥ 0 (the survival probability relative to the occurrence of censoring), and q(i)z denote the probability that
an individual in population i is of cohort z, and let p(i) = n(i)/(n(1) + n(2)). Suppose that θ(1)t = θ
(2)
t .
Then Θˆ d−→N(0, σ2), as n(i)→∞, with
σ2 =
2∑
i=1
(1− p(i))
 d∑
z=1
q
(i)
z φ
2
z −
(
d∑
z=1
q
(i)
z φz
)2
−
d∑
z=1
∫τz
0
dSz,tWz,t ×
(
φz,t
Sz,t
)2
,
where for 0≤ t ∧ τz , where τz is the time at which samples of cohort z are censored, φz,t =
∫τz
t ds Sz,s,
φz ≡ φz,0, Sz,t is the survival function for the pooled data of cohort z, and
Wz,t =
p(1)C(1)z,t−q(2)z + p(2)C(2)z,t−q(1)z
C
(1)
z,t−C
(2)
z,t−
 .
Note that this quantity is well-defined since by definition of τz , C
(z)
z,t > 0 for all t≤ τz . The variance σ2
may be consistently estimated by
σˆ2 =
2∑
i=1
(1− p(i))
 d∑
z=1
qˆ
(i)
z φˆ
2
z −
(
d∑
z=1
qˆ
(i)
z φˆz
)2
−
d∑
z=1
∫τz
0
dSˆz,t Wˆz,t ×
(
φˆz,t
Sˆz,t
)2
, (2.5)
where for 0≤ t ∧ τz , Sˆz,t is the product-limit estimate of the pooled data for cohort z,
φˆz,t =
∫τz
t
ds Sˆz,s, (2.6)
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Cˆ
(i)
z,t is the product-limit estimate associated to the event of censoring for cohort z within population i,
φˆz ≡ φˆz,0, and
Wˆz,t =
p(1)Cˆ(1)z,t−qˆ(2)z + p(2)Cˆ(2)z,t−qˆ(1)z
Cˆ
(1)
z,t−Cˆ
(2)
z,t−
 . (2.7)
Note that this quantity is also well-defined since Cˆ(z)z,t > 0 for all t≤ τz . In Appendix A,
we provide a proof of Theorem 1 in an empirical process framework. Note that since survival
estimates θˆ and Sˆ are step functions, all integrals are exactly computable.
3. Numerical investigation
A computational implementation of the test statistic Θˆ and weighted survival estimators is
available in the form of a package for R. This package also contains a class to handle arithmetic
involving right-continuous piecewise linear functions. In the appendices we have provided
source code that may be used for installing and invoking this package.
Here, we present a computational investigation of the weighted survival curve estimator and
the corresponding test statistic. Using simulations, we investigated the statistical power of Θˆ,
contrasted with that of existing non-parametric methods. Using a real dataset, we demonstrate
the computation of Θˆ, θˆt, and evaluate Type-I error.
(a) Evaluating statistical power through simulations
Using simulations, we explored the statistical power of the test statistic Θˆ in a case where
populations are difficult to distinguish based purely on mean survival time. As test populations,
we examined admixtures of exponential and Weibull distributions for the event time, and
compared survival in these mixture populations to survival of a population of purely exponential
event times (Fig. 2). Population 1 consists of individuals having an exponentially distributed
lifetime with a mean of λ−1 = 4 years. Population 2 consists of two types of individuals: those
who have an exponentially distributed lifetime with a mean of 5 years (type z = 1), and those
of type z = 2 who have a Weibull distributed lifetime with shape parameter k= 5 and scale
parameter λ= 1.
Since Population 1 is homogeneous, we only track subpopulations of Population 2 - we
drop the superscript and denote the proportion of Population 2’s members of type 2 by q2. It
is most instructive to examine our method in the neighborhood where both populations have
approximately the same expectation value for the event time, which occurs for q2 ≈ 0.245. For
this reason, we chose values near 0.25 for our simulations.
To compare the reweighted Kaplan-Meier estimator (Eq. 2.2) to the standard Kaplan-Meier
estimator, we estimated survival for the admixed population for q2 = 0.25, using various
sample sizes. In Fig. 3, we present example reconstructions using these two methods. The
estimator variance was approximated using 10, 000 resamplings of sample size n of the admixed
population, for each value of n. The estimation error, as defined by mean-squared difference
between the reconstruction and the true survival function, was approximated in the same manner.
To better-understand the performance of the test statistic (Eq. 2.4), we evaluated its statistical
power against that of other test statistics in distinguishing between Population 1 and Population
2 for various values of q2. For samples of size n(i) ∈ {30, 50, 100, 200, 1000} taken from each
population, we performed 1000 null hypothesis statistical tests using our method, the log-
rank method [2], and the standard Kaplan-Meier Wilcoxon signed-rank difference-of-mean
methods [18,21]. The power of the test, or the proportion of times that the null hypothesis was
correctly rejected, is shown in Fig. 4.
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Figure 2. Admixture test distributions used in simulated investigations of our estimator. Populations formed using q2 ∈
[0, 1) admixtures of (1− q2)exponential(λ= 5−1) and q2Weibull(k= 5, λ= 1) event time distributions. Event
time density functions pit and corresponding survival functions St are shown for various values of q2.
(b) Evaluating Type-I error in a real world example
We applied the survival estimator and statistic to NCCTG Lung Cancer data [13] available within
the survival package for R. We compared the survival between male (n(1) = 136) and female
(n(2) = 90) cancer patients, organized by ECOG performance score (z ∈ {0, 1, 2}) as cohort. Using
males as population 1 and females as population 2, we arrived at the test-statistic estimate: Θˆ=
−961, with 95% asymptotic confidence interval: (−1527,−396), which would support rejection
(P ≈ 0.0009) of the null hypothesis (θˆ(1)t = θˆ(2)t ) at α= 0.05. For reference, both the Wilcoxon (P ≈
0.0012) and log-rank (P ≈ 0.0015) tests referenced in Fig. 4 also rejected the null hypothesis.
In theory, the Type-I error is set by the significance level at study design. Whether a statistic
controls Type-I error correctly depends on accurate evaluation of its sampling distribution. In
the case of Θˆ, our main result is that the sampling distribution for this estimator converges
asymptotically in distribution to a Gaussian with a definite variance. However, small-sample
behavior is not guaranteed. To evaluate Type-I error, we used the same dataset, restricted to
male patients. For each of n∈ {40, 80, 136}, we sampled without replacement the n male patients
split into two groups so that n(1) = n(2) = n/2, and compared survival between the two random
groups. Repeating this procedure 10, 000 times, we generated the observed distribution of P -
values, presented in Fig. 6 in log-scale. The distributions computed using the three methods are
similar. The three methods all rejected H0 approximately 5% of the time except for the case of Θˆ
at n= 40, which rejected H0 approximately 6% of the time. Essentially, asymptotic convergence
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Figure 3. Comparing estimators of survival. The survival estimation method of Eq. 2.2 compared to pure Kaplan-
Meier for a population containing an admixture of (1− q2)Exponential(1/5) and q2Weibull(1, 5) individuals, where
q2 = 0.25. At a given sample size n, the survival estimates are obtained (top row: examples shown and contrasted). The
estimator variance and mean square error were approximated using 10, 000 resamplings for each of the sample sizes.
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Figure 4. Simulated power computation comparing exponentially distributed lifetimes against a mixture of q2 Weibull
and (1− q2) exponential distributions, where q2 determines the amount of mixing. A larger value of q2 implies more
real difference between the survival functions of the two populations. The power of our method (black) is compared to the
power of Kaplan-Meier Wilcoxon signed rank (blue) and Log-rank (red) methods. (More power is better).
as defined by the accurate evaluation of α= 0.05 Type-I error occurs somewhere in between 40
and 80 samples for this particular dataset.
Probing deeper, we examined the sampling distributions of Θˆ for each of n∈ {50, 60, 70}, in
each instance compared to the Gaussian distribution stated in Thm. 1, where the approximation
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Figure 5. θˆt estimates for days of lung cancer survival in males (population 1) versus females (population 2) from the
NCCTG lung cancer dataset. The statistic Θˆ implies an asymptotic P -value of 0.0009, rejecting H0 at α= 0.05.
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Figure 6. P -value distributions for the comparison between samples of size n/2 of two random subpopulations of
male patients in the lung cancer data. The proportion of null hypotheses rejected at each of the three statistical methods
is similar, at approximately 5% for α= 0.05.
is computed using only the first sample of size n. The results for these simulations are shown
in Fig. 7, where it is seen that the sampling distribution of Θˆ is approximately the same as the
computed asymptotic Gaussian distribution, which is traced out in red.
The R code used to compute these examples is available in Appendix B(c).
4. Discussion and Conclusion
In this manuscript we have proposed a test statistic that uses a cohort-averaged survival function
estimator in order to make cross-population comparisons of survival within a null hypothesis
statistical testing framework. The proposed survival estimator was an empirically-weighted
average of cohort-level product-limit estimates. The test statistic involved computation of the area
between estimated survival functions for two populations. By invoking an empirical stochastic
process, we proved asymptotic normality of this test statistic.
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Figure 7. Histograms of Θˆ sampling distributions for comparing survival between random subsets of male lung
cancer patients using sample sizes of n∈ {50, 60, 70}. Traced in red, the asymptotic Gaussian density as computed
using Thm. 1 on the first sample set of each size is overlayed.
Using simulations, we contrasted the weighted survival estimator against the pure Kaplan-
Meier estimator. It is seen, in Fig. 3, that the survival curves generated from the two methods
are distinct yet similar. In the second and third rows of Fig. 3, one sees that this reweighted
estimator has comparable performance to the pure Kaplan-Meier estimator at large sample sizes.
Asymptotically, both estimators converge to the true survival function, with variance converging
to zero. At small sample sizes, there are differences. The reweighted estimator has reduced
variance at the cost of larger bias, in a time-dependent manner. It also appears to have smaller
variance at the cost of larger error at earlier times. This error at earlier times is mitigated by
decreased error at later times (better reconstruction of tails), however, the estimator variance is
lower at all times. Hence, dependent on costs, for small samples, this reweighted estimator may
be preferable to the pure Kaplan-Meier estimator.
In simulations of the test statistic derived from the reweighted survival estimator, we saw
superior performance compared to existing methods. In Fig. 4, it is seen that in all cases, the test
statistic Θˆ was better at distinguishing between the two populations than either the Wilcoxon
signed-rank test or the log-rank test. The relatively-high statistical power of this statistic is due to
tighter variation in the test-statistic. In nearly all cases (> 99.5%), the estimator variance for the
tested method was less than that of the other two tests (not shown).
This manuscript derives the asymptotic convergence in distribution of the Θˆ statistic.
Numerically, we demonstrated convergence of the statistic in Figs. 6 and 7, where we verified
that the asymptotic approximation respects Type-I error at α= 0.05 and where we observe good
match between the sampling distribution of Θˆ and the asymptotic Gaussian distribution provided
by Thm. 1.
A variant of this method was used in Rasch et al. [17] in order to classify physical
disorders based on severity for the sake of prioritization of processing for disability claims.
Since the underlying survival surface is non-stationary, and the fixed observation windows
create progressive censoring, that paper illustrates the utility of this statistical method. In that
manuscript, the cohorts were defined based on binned application entry times and a heuristic
“survival surface” was generated in order to get a single overall picture of the survivability
of a given disorder. The censoring parameters τz varied due to the finite sampling window
and the fact that more-recent cohorts are not observed for as long a time period as older
cohorts, as depicted in Fig 1b. It was also expected that survival by cohort would vary due to
differences in health care administration and treatment between entry cohorts. The use of the
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empirical prevalences (qˆz) allowed the accounting for variability in disability application volume
by sufferers of given disorders, conditional on entry date.
We note that a strong limitation of the presented method lies in its framing in terms of null
hypothesis statistical testing. The Θˆ statistic only provides a P -value, as opposed to other tests
such as the log-rank test which provide hazard ratios as well. As a trade-off for statistical power,
one is sacrificing interpretability in the form of effect sizes.
Although the most direct and natural applications of the method that we have presented here
involve discretely-indexed covariates, it is possible to use this method for continuously-indexed
covariates such as time by employing the binning strategy used in Rasch et al. [17]. This approach
is particularly fruitful if the sampling windows are coarse and there is clear separation between
cohorts to maintain statistical independence. In this situation, it may be unreasonable to expect
to construct a full continuous surface for survival. Nonetheless, a possible future extension of
this method might involve replacing the sum of Eq. 2.1 with an integral and using statistical
regularization tools [5] in order to infer true continuously-indexed surfaces.
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A. Proof of the main theorem
To prove the main theorem, we use an empirical process modeling framework to develop
the asymptotic properties of first deterministically proportionally-weighted Kaplan-Meier
estimators. We then replace the deterministic proportions with estimates given by the sample
prevalences of the cohorts. Here, we restate the main theorem and prove it through a series of
lemmata.
Theorem 1. Let C(i)z,t denote the probability that a z-type individual has not yet been censored at time
t≥ 0 (the survival probability relative to the occurrence of censoring), and q(i)z denote the probability that
an individual in population i is of cohort z, and let p(i) = n(i)/(n(1) + n(2)). Suppose that θ(1)t = θ
(2)
t .
Then Θˆ d−→N(0, σ2), as n(i)→∞, with
σ2 =
2∑
i=1
(1− p(i))
 d∑
z=1
q
(i)
z φ
2
z −
(
d∑
z=1
q
(i)
z φz
)2
−
d∑
z=1
∫τz
0
dSz,tWz,t ×
(
φz,t
Sz,t
)2
,
where for 0≤ t ∧ τz , where τz is the time at which samples of cohort z are censored, φz,t =
∫τz
t ds Sz,s,
φz ≡ φz,0, Sz,t is the survival function for the pooled data of cohort z, and
Wz,t =
p(1)C(1)z,t−q(2)z + p(2)C(2)z,t−q(1)z
C
(1)
z,t−C
(2)
z,t−
 .
The variance σ2 may be consistently estimated by
σˆ2 =
2∑
i=1
(1− p(i))
 d∑
z=1
qˆ
(i)
z φˆ
2
z −
(
d∑
z=1
qˆ
(i)
z φˆz
)2
−
d∑
z=1
∫τz
0
dSˆz,t Wˆz,t ×
(
φˆz,t
Sˆz,t
)2
, (A 1)
where for 0≤ t ∧ τz , Sˆz,t is the product-limit estimate of the pooled data for cohort z,
φˆz,t =
∫τz
t
ds Sˆz,s, (A 2)
Cˆ
(i)
z,t is the product-limit estimate associated to the event of censoring for cohort z within population i,
φˆz ≡ φˆz,0, and
Wˆz,t =
p(1)Cˆ(1)z,t−qˆ(2)z + p(2)Cˆ(2)z,t−qˆ(1)z
Cˆ
(1)
z,t−Cˆ
(2)
z,t−
 . (A 3)
Overview of Proof of Theorem 1. To prove the main theorem, we turn to the modeling framework
that we present in (b). In general, we proceed by first assuming fixed sample proportions and
then extending results to random proportions as given by empirical prevalence (Eq 2.3). The
convergence of Θˆ follows directly from corollary 10 and Eq. A 18. The consistency of σˆ2 follows
from theorem 4.2.2 of [7], which provides for weak convergence of the product limit estimator to
a Gaussian process, and the Glivenko-Cantelli theorem.
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(a) Preliminaries and Notation
Given any pair of random elements X,Y , we denote equality in a distributional sense by X ≈ Y .
Let P be a probability measure on the measurable space (X,A). The empirical measure generated
by the sample of random elements x1, . . . , xn, n∈N is given by
Pn = n−1
n∑
i=1
δxi , (A 4)
where for any x∈X , and any A∈A,
δx(A) =
{
1, x∈A,
0, x /∈A. (A 5)
Note that alternatively, when needed, one may write δx(A) as the indicator function 1A(x) on the
set A. Furthermore, in the case that A= {k}, k ∈Z, and x∈Z, we write δx(A)≡ δx,k.
GivenH, a class of measurable functions h :X→R, the empirical measure generates the map
H→R given by h 7→ Pnh, where for any signed measure Q and measurable function h, we use
the notation Qh=
∫
dQh. Furthermore, define theH-indexed empirical process Gn by
Gnh=
√
n (Pn − P)h= 1√
n
n∑
i=1
(h(xi)− Ph) , (A 6)
and with the empirical process, identify the signed measure Gn = n−1/2∑ni=1 (δxi − P).
Note that for a measurable function h, from the law of large numbers and the central limit
theorem, it follows that Pnh
a.s.−−→ Ph, and Gnh d−→N
(
0,P (h− Ph)2
)
, provided Ph exists and
Ph2 <∞, and where “ d−→” denotes convergence in distribution. In addition to the preceding
notation, given the elements f , and fn, n∈N, we also denote respectively, convergence in
probability and in distribution, of fn to f , by fn
p−→ f .
For any map x :H→Rk, k ∈N, define the uniform norm ‖x‖H by
‖x‖H = sup {|x(h)| : h∈H}, (A 7)
and in the case that H⊂R, write ‖·‖H ≡ ‖·‖∞. A class H for which ‖Pn − P‖H→ 0 is called a
P-Glivenko-Cantelli class. Denote by `∞(H) the class of uniformly bounded functions onH. That
is, for a general k ∈N,
`∞(H) =
{
x :H→Rk : ‖x‖H <∞
}
.
If for some tight Borel measurable element G ∈ `∞(H), Gn d−→G, in `∞(H), we say that H is a
P-Donsker class.
(b) Empirical process framework
To prove Theorem 1, we turn to an empirical modeling framework that will provide us the
asymptotic statistics of the weighted product limit estimator. Consider a closed particle-system,
such that according to a predefined set of characteristics, the system can be subdivided into
mutually exclusive subsystems.
Each particle corresponds to the observed state of a particular individual in a fixed population
cohort. Note that we will restrict this discussion to only a single population of particles. These
arguments will extend to multiple populations as mentioned in this manuscript by treating
separate populations as independent.
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At any given time t≥ 0, each particle will have exactly one associated state x in the set Z4,
referring respectively to states of
0 dormancy
1 activity
2 inactivity
3 censored.
(A 8)
Assume that the path of any particle is statistically dependent upon its particular subsystem, and
that given the respective subsystems of any two particles, their resulting paths are statistically
independent. Assume further that at a reference time t= 0, all particles enter into the active state
(x= 1), and that particles are considered dormant for all t < 0.
Let d∈N and τ ∈ (0,∞) be fixed. We will assume the existence of a collection of individuals
Γ , assumed to be infinite in size, where each individual γ ∈ Γ exhibits a càdlàg path-valued state
xγt , for t≥ 0. For each γ ∈ Γ , xγt is determined by the individuals particle type zγ and a random
jump time ξγ . The particle type zγ is distributed in the population through the probability mass
P(zγ = z) = qz , where q= (q1, . . . , qd)∈ (0, 1)d satisfies
∑d
z=1 qz = 1. Let St = (S1,t, . . . , Sd,t) be
the survival vector Sz,t = P {Tz > t}, which is assumed continuous for t≥ 0. Suppose that it
is desired to understand the event probabilities for randomly selected γ ∈ Γ , unconditional on
subgroup membership. We assume that members of each cohort are in the inactive (0) state at
times t < 0.
Given a random sample γ1, . . . , γn, n∈N of individuals, let n= (n1, . . . , nd) and
n=
d∑
z=1
nz (A 9)
where nz is the random number of drawn individuals of cohort z. In considering the event
time probabilities of each subgroup, the random number of particles excludes the use of many
well established results in survival analysis. Therefore, we begin with a somewhat restricted
framework, and assume a known number of initial individuals of each type.
Assume the sample contains a known number nz = azn, az ∈ (0, 1), of individuals of cohort
z, and let µnzj,z,t ≥ 0 be the number of the cohort z individuals who are in state j ∈Z4 at time t, so
that
3∑
j=0
µnzj,z,t = nz (A 10)
is conserved. Also, we assume that there exists τz <∞ when all particles either become inactive
or censored so that τz is the infimum time where the condition
nz = µ
nz
2,z,t + µ
nz
3,z,t ∀t > τz (A 11)
holds.
For the sample of size nz , we denote the z-type cumulative hazard by Λz,t and respectively
define the z-type cumulative hazard and survival estimates by
Λˆnzz,t =
∫ t
0
dµnz2,z,s
µnz1,z,s−
(A 12)
Sˆnzz,t =
∏
s≤t
(
1− dΛˆnzz,s
)
. (A 13)
Define further
Bnzz,t =
√
nz
Sˆnzz,t − Sz,t
Sz,t
and note that Sˆnzz,t = Sˆ
nz
z,τz and B
nz
z,t =B
nz
z,τz for all t≥ τz .
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From [7], it follows that
{
Bnzz,t : t≥ 0
}
is a mean-zero square-integrable martingale with Meyer
bracket process
〈
Bnzz,t, B
nz
w,t
〉
t
= δzwnz
∫ t∧τz
0
dΛz,s
(
Sˆnzz,s−
Sz,s
)2 1{
µnz1,z,s−>0
}
µnz1,z,s−
, (A 14)
where t ∧ τz =min{t, τz}, and δ(·,·) is the Kroenicker delta function.
(c) Convergence Theorems
In order to guarantee convergence of the estimator, we make the following assumptions (based
upon an initially known sample size distribution n).
Assumption 2. We assume that the initial sample is chosen large enough to ensure that individuals of
cohort z, at state 1 (active), exist at all points t∈ [0, τz ], z ∈ {1, . . . , d}. That is,
inf
z∈Nd
µnz1,z,τz− > 0, a.s.
Since any survival function is monotone, an immediate result that follows from the above is
assumption is
c < Sz,τz ≤ Sz,t ≤ 1, t≥ 0, (A 15)
for some constant c > 0.
Assumption 3. It is assumed that as n becomes large, the sample size for each individual type will grow
to infinity. That is,
lim
n→∞ infz∈Nd,a∈V
µnaz1,z,τz− =∞, a.s.
Assumption 4. For each z ∈ {1, . . . , d} there exists a non-increasing continuous functionmz : [0,∞)→
(0, 1] such that
lim
n→∞ supt≥0
∣∣∣∣∣µ
naz
1,z,t
naz
−mz,t
∣∣∣∣∣= 0 a.s.
Note that in the case of fixed censoring, that is, in the case that censoring exists only at time τ ,
the above is satisfied bymz,t = Sz,t. In the general case,mz,t can be seen as the probability that an
individual of cohort z has not yet left state 1. That is,mz,t is the probability that an individual has
not left due to censoring or death by time t, and somz,t = Sz,tCz,t−, where Cz,t is the probability
that censoring has not occurred by time t.
To prove the main theorem, we now present a series of lemmata.
Lemma 5. If qˆ is defined is in Eq. 2.3 and Sˆnzz,s− is defined as in Eq. A 13, then
√
n
d∑
z=1
(qˆz − qz)
∫ t∧τz
0
ds
(
Sˆnqˆzz,s− − Sz,s
)
p−→ 0,
as n→∞, uniformly in t≥ 0.
Proof. It is claimed that to prove the statement of the lemma, it suffices to show that
sup
t≥0
(
Sˆnqˆzz,t− − Sz,t
Sz,t
)2
p−→ 0, (A 16)
uniformly in t≥ 0, for each z = 1, . . . , d.
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Indeed, for if the above holds, then
∫ t∧τz
0
ds
(
Sˆnqˆzz,s− − Sz,s
)
p−→ 0,
uniformly in t≥ 0. Since the central limit theorem implies that √n(qˆz − qz) d−→N(0, qz(1− qz)),
each term in the sum would converge in probability to 0, uniformly in t≥ 0.
And so, if EN denotes the expectation given N , we have that
E
(
Sˆnqˆzz,t− − Sz,t
Sz,t
)2
=E 1
nqˆz
Enqˆz
(
Bnqˆzz,t
)2
=E 1
nqˆz
Enqˆznqˆz
∫ t∧τz
0
dΛz,s
µnqˆz1,z,s−
(
Sˆnqˆzz,s−
Sz,s
)
=E
∫ t∧τz
0
dΛz,s
µnqˆz1,z,s−
(
Sˆnqˆzz,s−
Sz,s
)
≤CE
(
µnqˆz1,z,τz
)−1
,
for some arbitrary constant C. From Lenglart’s inequality (cf. [11]),
P
supt
(
Sˆnqˆzz,t− − Sz,t
Sz,t
)2
> 
≤ η + P
{
µnqˆz1,z,τz− <
C
η
}
,
for any arbitrary η,  > 0. Therefore, from Assumption 3, since nz→∞ a.s., the desired result
follows.
Turning momentarily to the situation where there are two populations denoted by superscripts
(1), and (2), for any t≥ 0, define
Θˆδt =
√
n(2)
n(1) + n(2)
∫ t∧τ
0
ds
√
n(1)(θˆ
(1)
s− − θ(1)s )
−
√
n(1)
n(1) + n(2)
∫ t∧τ
0
ds
√
n(2)(θˆ
(2)
s− − θ(2)s ),
noting that setting θ(1)s = θ
(2)
s recovers our test statistic of Eq. 2.4. For a general survival function
θ, with respective estimate θˆ, define Yˆt by
Yˆt =
∫ t∧τ
0
ds
√
n
(
θˆs− − θs
)
, t≥ 0. (A 17)
If the process Yˆ converges in distribution to some Y ∼N(0, σ2), since n(i)/(n(1) + n(2))
converges to p(i), i= 1, 2, it follows that
Θˆδt
d−→
√
p(2)Y
(1)
t −
√
p(1)Y
(2)
t ≈N(0, p(2)σ21 + p(1)σ22). (A 18)
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Now we turn to analysis under a single population, dropping the superscripts. Note that Yˆt =∑d
z=1 Zˆz,t, where
Zˆz,t =
√
n
∫ t∧τz
0
ds
(
qˆzSˆ
nqˆz
z,s− − qzSz,s
)
(A 19)
=
√
n(qˆz − qz)
∫ t∧τz
0
ds
(
Sˆnqˆzz,s− − Sz,s
)
+
√
n(qˆz − qz)
∫ t∧τz
0
ds Sz,s
+
√
nqz
∫ t∧τz
0
ds (Sˆnqˆzz,s− − Sz,s)
Therefore, if it can be shown that
√
n
d∑
z=1
(qˆz − qz)
∫ t∧τz
0
ds
(
Sˆnqˆzz,s− − Sz,s
)
p−→ 0,
uniformly in t, then convergence of (Yˆt : t≥ 0) is dependent only upon the convergence of the
d-dimensional vector-valued process ζˆ(qˆ) given by
ζˆz,t(a) =
√
n(qˆz − qz)
∫ t∧τz
0
ds Sz,s
+
√
nqz
∫ t∧τz
0
ds (Sˆnazz,s− − Sz,s), (A 20)
with a= (a1, . . . , ad)∈ (0, 1)d chosen in a sufficiently small neighborhood V of q. This
decomposition will thus lead to the main theorem. To show the desired convergence of ζˆt(qˆ),
we first focus on convergence of ζˆt(a).
Let φz,t =
∫τz
t ds Sz,s and write ζˆt(a) = ζˆ
1
t + ζˆ
2
t (a), where
ζˆ1z,t =
√
n (qˆz − qz)
∫ t∧τz
0
(−dφz,s), (A 21)
and
ζˆ2z,t(a) =
qz√
az
∫ t∧τz
0
(−dφz,s)Bnazz,s , (A 22)
Lemma 6. Suppose that
{
ζˆ1t (a) : t≥ 0
}
and
{
ζˆ2t (a) : t≥ 0
}
are the processes respectively defined by
equations (A 21) and (A 22), and that B˜ is the d-dimensional mean-zero Gaussian process defined by〈
B˜z , B˜w
〉
t
= δz,w
∫ t∧τz
0
dΛz,s
Sz,sCz,s−
. (A 23)
Then ζˆ1t
d−→ ζ1t and ζˆ2t (a) d−→ ζ2t (a), in the space of compactly supported functions DRd [0,∞) as n→
∞, for each a∈ V , where ζ1t = (ζ11,t, . . . , ζ1d,t) is the mean-zero square-integrable Gaussian process defined
by 〈
ζ1z , ζ
1
w
〉
t
(A 24)
=−qzqw
(∫ t∧τz
0
ds Sz,s
)(∫ t∧τw
0
ds Sw,s
)
+ δz,wqz
(∫ t∧τz
0
ds Sz,s
)2
,
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and ζ2t (a) = (ζ
2
1,t(a), . . . , ζ
2
d,t) is given by
ζ2z,t(a) =
qz√
az
(∫ t∧τz
0
dB˜z,sφz,s − φz,t∧τz B˜z,t∧τz
)
(A 25)
The processes ζˆ1 and ζˆ2(a) are independent, and there exist a Skorohod representations such that
sup
t≥0
∣∣∣ζˆ1z,t − ζ1z,t∣∣∣→ 0,
and
sup
t≥0,a∈V
∣∣∣ζˆ2z,t(a)− ζ2z,t(a)∣∣∣→ 0,
almost surely as n→∞.
Proof. To begin note that independence follows immediately from the independence of the
respective limiting processes. Since n is a multinomial random variable, (A 24) follows from the
central limit theorem. In the case of ζˆ2t (a), we first consider B
naz
z,t .
An application of Lenglart’s inequality, very similar to that in the proof of Lemma 5, along
with Assumption 3, shows that
sup
a∈V,t≥0
∣∣∣Sˆnazz,t− − Sz,t∣∣∣ p−→ 0, as n→∞.
Moreover, from Assumption 4,
sup
a∈V,t≥0
∣∣∣∣∣ nazµnaz1,z,t− − 1mz,t
∣∣∣∣∣ p−→ 0, as n→∞.
It follows that
naz
µnaz1,z,t−
(
Sˆnazz,t−
Sz,t
)2
p−→ 1
mz,t
,
uniformly in t≥ 0, and since mz,t = Sz,tCz,t−,〈
Bnazz,t , B
naz
w,t
〉
t
p−→ δz,w
∫ t∧τz
0
dΛz,s
Sz,sCz,s−
.
Therefore, from theorem 4.2.1 of [7], Bnazz,t
d−→ B˜z,t, and there exists a Skorohod representation
of Bnazz,t such that
sup
t≥0,a∈V
∣∣∣Bnazz,t − B˜z,t∣∣∣→ 0,
almost surely as n→∞. Since almost sure convergence of Bnazz,t implies almost sure convergence
of bounded functionals of Bnazz,t , the desired convergence of ζˆ
2(a) follows from Theorem 2.1 of
[6].
Corollary 7. If the process ζˆ(a) =
{
ζˆt(a)
}
is defined by equation (A 20), then
d∑
z=1
ζˆz(a)
d−→
d∑
z=1
ζz,t(a) (A 26)
=
d∑
z=1
ζ1z,t + ζ
2
z,t(a).
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Proof. From the previous theorem we may assume that ζˆ1z,t→ ζ1z,t and ζˆ2z,t(a)→ ζ2z,t(a) almost
surely, uniformly for a∈ V and t≥ 0. Therefore
ζˆt(a)→ ζt(a)
almost surely, uniformly for a∈ V and t≥ 0. The statement of the theorem then follows from
theorem 5.1 of [3].
Since n/n
p−→ q, from Theorem 4.4 of [3](
n
n
,
{
d∑
z=1
ζˆz,t(a) : t≥ 0
})
d−→
(
q,
{
d∑
z=1
ζz,t(a) : t≥ 0
})
.
Define the map g : V × `∞(V × [0,∞))→ `∞([0,∞)) by g(a, f) = f(a, ·), then
d∑
z=1
ζz,t
(n
n
)
= g
(
n
n
,
d∑
z=1
ζz
)
.
Furthermore, if for any (a1, f1), (a2, f2)∈ V × `∞(V × [0,∞)) we have that
|a1 − a2|+ sup
a∈V,t≥0
|f1(a, t)− f2(a, t)|< δ
for some δ > 0, then
sup
t≥0
|g(a1, f1)(t)− g(a2, f2)(t)|
= sup
t≥0
|f1(a1, t)− f2(a2, t)|
≤ sup
t≥0
|f1(a1, t)− f1(a2, t)|+ sup
t≥0
|f1(a2, t)− f2(a2, t)| .
Therefore, g is a continuous at any (a, f) such that f is continuous at a, uniformly in t. It thus
follows from the continuous mapping theorem (cf. [20]) that if a 7→∑dz=1 ζz,t(a) is continuous,
uniformly in t, then
g
(
n
n
,
d∑
z=1
ζˆz
)
d−→ g
(
q,
d∑
z=1
ζz
)
. (A 27)
Lemma 8. If {ζt(a) : t≥ 0} is defined as in Corollary 7, then the map
a 7→
d∑
z=1
ζz,t(a)
is continuous for a∈ V , uniformly in t≥ 0.
Proof. For any a, b∈ V , it follows that
d∑
z=1
ζz,t(a)−
d∑
z=1
ζz,t(b)
=
d∑
z=1
qz
(
1√
az
− 1√
bz
)
×
(
φz,t∧τz B˜z,t∧τz −
∫ t∧τz
0
dB˜z,sφz,s
)
.
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Since Sτz > 0 for all z, from Doob’s martingale inequality (cf. [10]),
E sup
t≥0
(
d∑
z=1
ζz,t(a)−
d∑
z=1
ζz,t(b)
)2
≤C
d∑
z=1
(
1√
az
− 1√
bz
)2
,
for some arbitrary constant C. For each z ∈Nd, since az and bz are sufficiently close to qz ∈ (0, 1),
it follows that there exists some δ > 0 such that az ∧ bz > δ. Therefore,
(
1√
az
− 1√
bz
)2
=
1
azbz
(
√
az −
√
bz)
2
≤ δ−2(√az −
√
bz)
2
(√
az +
√
bz√
az +
√
bz
)2
≤ 1
4δ3
(az − bz)2.
Combining the above two results gives
E sup
t≥0
(
d∑
z=1
ζz,t(a)−
d∑
z=1
ζz,t(b)
)2
≤C |a− b|2 ,
and so, by Kolmogorov’s continuity criterion (cf. [10]), the desired result follows.
The above lemma, along with the argument immediately preceding, gives the following.
Theorem 9. Let
∑d
z=1 ζ
n
z,t(·) and
∑d
z=1 ζz,t(·) be defined as in Corollary 7, then
d∑
z=1
ζˆz,t
(n
n
)
d−→
d∑
z=1
ζz,t(q), in DR[0,∞), as n→∞. (A 28)
Corollary 10. If ζˆ =
∑d
z=1 ζz,τz (q), then
ζˆ ∼N(0, σ2),
where
σ2 =
d∑
z=1
qzφ
2
z,0 −
(
d∑
z=1
qzφz,0
)2
−
d∑
z=1
qz
∫τz
0
dSz,t
Cz,t−
(
φz,t
Sz,t
)2
Proof. Note that when t= τz , we have
ζz,τz (q) = ζ
1
z,τz +
√
qz
∫τz
0
dB˜z,t φz,t,
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which are independent and normally distributed, implying that ζˆ is also normally distributed.
Furthermore
Eζˆ2 =
d∑
z=1
(
ζ1z,τz +
√
qz
∫τz
0
dB˜z,tφz,t
)2
+
d∑
z,w=1
z 6=w
(
ζ1z,τz +
√
qz
∫τz
0
dB˜z,tφz,t
)
×
(
ζ1w,τw +
√
qz
∫τw
0
dB˜w,tφw,t
)
=
d∑
z=1
(
E
(
ζ1z,τz
)2
+ Eqz
(∫τz
0
dB˜z,tφz,t
)2)
−
d∑
z,w=1
z 6=w
Eζ1z,τzζ
1
w,τw
=
d∑
z=1
(
qz(1− qz)φ2z,0 + qz
∫τz
0
dΛz,t
φ2z,t
Sz,tCz,t−
)
−
d∑
z,w=1
z 6=w
qzqwφz,0φw,0,
which after recombining the final terms, gives the desired result.
B. Computation
(a) Installation of R package
The following code installs the R package from github sources
1 # install devtools if not already installed
2 install.packages("devtools")
3 library(devtools)
4 install_github("joshchang/calonesurv")
5 library(calonesurv)
(b) Simulation of data used in this manuscript
We simulated draws from the populations mentioned in the main text using the following R code:
1 library(survival)
2 library(calonesurv)
3
4 p = 0.75
5 n = 20
6 samples = 10000
7 tvals = seq(0,1/explambda*4,by=0.05)
8
9 explambda = 1/4
10 wshape = 1
11 wscale = 5
12
13 mix_results <- matrix(nrow = length(tvals), ncol = samples)
14 pure_results <- matrix(nrow = length(tvals), ncol = samples)
15
16 for(i in 1:samples){
17 n1 = sum(rbinom(n,1,p) )
18 n2 = n-n1
19 #while(n2<2){
20 # n1 = sum(rbinom(n,1,p) )
21 # n2 = n-n1
22 #}
23 t1 = sort(rexp(n1,explambda))
24 t2 = sort(rweibull(n2,wshape,wscale))
25
26 km1 = cadlag(survfit(Surv(t1)~1))
27 km3 = cadlag(survfit(Surv(c(t1,t2))~1))
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28 pure <- cadlag(km3$time,c(1,km3$surv))
29
30 if(n2>0){
31 km2 = cadlag(survfit(Surv(t2)~1))
32 mix <- n1/n*km1 + n2/n*km2
33 mix_results[,i] <- mix(tvals)
34 }
35 else{
36 mix_results[,i] <- pure(tvals)
37 }
38
39 pure_results[,i] <- pure(tvals)
40 }
(c) Real-world example
1 require(coin)
2 require(survival)
3 source("Theta.R")
4 library(data.table)
5 library(ggplot2)
6
7 surv_data = with(subset(survival::lung,ph.ecog %in% 0:2),
8 data.frame(population = sex,
9 censor = as.numeric(status==1),
10 time = time, cohort = ph.ecog ))
11
12 out = Theta_hat(surv_data)
13 print(out)
14 print(confint(out))
15 print(pvalue.Theta_hat(out))
(i) Simulations for examining the sampling distribution of Θˆ
1
2 J = 10000
3 N = c(40,80,136)
4
5
6 typeone = data.table("method" = rep(0,J*length(N)*3), "n" = rep(0,J*length(N)*3), "P" = rnorm(J*length(N)*3))
7 Thetavals = data.table("n" = rep(0,J*length(N)), "Theta" = rep(0,J*length(N)))
8
9 # Simulations for evaluating Type-I error
10
11 k = 0
12 j = 1
13 for(n in N){
14 i = 1
15 while(i< J*3){
16 indices = sample(1:136,n)
17 s_data = subset(surv_data,population==1)[indices,]
18 s_data$population[1:(n/2)] = 2
19
20 tryCatch({
21 out = Theta_hat(s_data)
22 p_Theta_hat = pvalue.Theta_hat(out)
23 p_lr = pvalue(logrank_test(Surv(time,1-censor)~as.factor(population), data = s_data))
24 fit = survfit(Surv(time,1-censor)~as.factor(population), data = s_data)
25 t1 = ten(fit)
26 invisible(comp(t1))
27 p_w = attr(t1,’lrt’)$pNorm[2]
28 Thetavals[j] = list( "n" =n , "Theta" = as.numeric(out))
29 typeone[J*3*k + i,] = list("method"=1,"n"=n,"P" = p_Theta_hat)
30 typeone[J*3*k + i+1,] = list("method"=2,"n"=n,"P" = p_w)
31 # logrank is 3
32 typeone[J*3*k + i+2,] = list("method"=3,"n"=n,"P" = p_lr)
33 i = i + 3
34 j = j + 1
35 },error = function(err) print(err))
36
37 }
38 k = k+1
39 }
40 pdf("fig6.pdf",family="CM Roman", width=8, height=4)
41 typeone$method = as.factor(typeone$method)
42 levels(typeone$method) = c("Our Method", "Wilcoxon signed rank","Log-rank")
43 pp = ggplot(typeone, aes(factor(n),P))
44 print(pp + geom_violin(aes(fill=factor(method)))+geom_hline(aes(yintercept=0.05),linetype=’dashed’)+ ylim(1e-4,1)+
45 scale_y_continuous(trans=’log2’,breaks = c(0.0005,0.005,0.05,0.5,1),limits = c(1e-4,1)) + theme_bw() + theme(legend.position="
top") +
46 ylab("P-value") + xlab("Sample size") + guides(fill=guide_legend(title="Method: ")))
47 dev.off()
48
49
50 typeone$reject = typeone$P < 0.05
51 print(ftable(reject ~ method + n, data = typeone))
52
53
54 # Simulations for evaluating asymptotic convergence in distribution
55
56 Thetavals_2 = data.table("n" = rep(0,J*length(N)), "Theta" = rep(0,J*length(N)))
57
58 j = 1
59 for(n in c(50,60,70)){
60 i = 1
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61 while(i< J*3){
62 indices = sample(1:136,n)
63 s_data = subset(surv_data,population==1)[indices,]
64 s_data$population[1:(n/2)] = 2
65 tryCatch({
66 out = Theta_hat(s_data)
67 Thetavals_2[j] = list( "n" =n , "Theta" = as.numeric(out))
68 j = j + 1
69 i = i + 3
70 },error = function(err) print(err))
71
72 }
73 }
74
75 # compute the theoretical Gaussian densities
76
77 n = 50
78 indices = sample(1:136,n)
79 s_data = subset(surv_data,population==1)[indices,]
80 s_data$population[1:(n/2)] = 2
81 out_50 = Theta_hat(s_data)
82
83 n = 60
84 indices = sample(1:136,n)
85 s_data = subset(surv_data,population==1)[indices,]
86 s_data$population[1:(n/2)] = 2
87 out_60 = Theta_hat(s_data)
88
89 n = 70
90 indices = sample(1:136,n)
91 s_data = subset(surv_data,population==1)[indices,]
92 s_data$population[1:(n/2)] = 2
93 out_70 = Theta_hat(s_data)
94
95 grid <- with(dd, seq(-750,750, length = 200))
96 normaldens =
97 data.frame(
98 Theta = rep(grid,3),
99 n = rep(c(50,60,70),each=length(grid)),
100 density = c(dnorm(grid, mean = 0, sd = sqrt(slot(out_50,’variance’))),
101 dnorm(grid, 0, sqrt(slot(out_60,’variance’))),
102 dnorm(grid, 0, sqrt(slot(out_70,’variance’))))
103 )
104
105
106 pdf("fig7.pdf",family="CM Roman", width=8, height=3)
107 pp2 = ggplot(Thetavals_2,aes(Theta)) + geom_histogram(aes(x = Theta, y = ..density..),bins = 80,fill = "grey") + facet_wrap(~n)
+
108 theme_bw() + xlab(expression(hat(Theta)))+
109 geom_line(aes(y = density), data = normaldens, colour = "red", size=1.1)
110 print(pp2)
111 dev.off()
